Literature DB >> 21968453

Reliable protein production in a Pseudomonas fluorescens expression system.

Diane M Retallack1, Hongfan Jin, Lawrence Chew.   

Abstract

A bottleneck to product development can be reliable expression of active target protein. A wide array of recombinant proteins in development, including an ever growing number of non-natural proteins, is being expressed in a variety of expression systems. A Pseudomonas fluorescens expression platform has been developed specifically for recombinant protein production. The development of an integrated molecular toolbox of expression elements and host strains, along with automation of strain screening is described. Examples of strain screening and scale-up experiments show rapid development of expression strains producing a wide variety of proteins in a soluble active form.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21968453     DOI: 10.1016/j.pep.2011.09.010

Source DB:  PubMed          Journal:  Protein Expr Purif        ISSN: 1046-5928            Impact factor:   1.650


  13 in total

1.  A Robust CRISPR Interference Gene Repression System in Pseudomonas.

Authors:  Sue Zanne Tan; Christopher R Reisch; Kristala L J Prather
Journal:  J Bacteriol       Date:  2018-03-12       Impact factor: 3.490

Review 2.  Non-conventional expression systems for the production of vaccine proteins and immunotherapeutic molecules.

Authors:  Isabelle Legastelois; Sophie Buffin; Isabelle Peubez; Charlotte Mignon; Régis Sodoyer; Bettina Werle
Journal:  Hum Vaccin Immunother       Date:  2016-12-01       Impact factor: 3.452

3.  Lipase and protease double-deletion mutant of Pseudomonas fluorescens suitable for extracellular protein production.

Authors:  Myunghan Son; Yuseok Moon; Mi Jin Oh; Sang Bin Han; Ki Hyun Park; Jung-Gon Kim; Jung Hoon Ahn
Journal:  Appl Environ Microbiol       Date:  2012-10-05       Impact factor: 4.792

4.  Immunization with a Recombinant, Pseudomonas fluorescens-Expressed, Mutant Form of Bacillus anthracis-Derived Protective Antigen Protects Rabbits from Anthrax Infection.

Authors:  Matthew D Reed; Julie A Wilder; William M Mega; Julie A Hutt; Philip J Kuehl; Michelle W Valderas; Lawrence L Chew; Bertrand C Liang; Charles H Squires
Journal:  PLoS One       Date:  2015-07-24       Impact factor: 3.240

5.  Pseudomonas stutzeri as an alternative host for membrane proteins.

Authors:  Manuel Sommer; Hao Xie; Hartmut Michel
Journal:  Microb Cell Fact       Date:  2017-09-20       Impact factor: 5.328

6.  The Plasmodium falciparum Cell-Traversal Protein for Ookinetes and Sporozoites as a Candidate for Preerythrocytic and Transmission-Blocking Vaccines.

Authors:  Diego A Espinosa; Joel Vega-Rodriguez; Yevel Flores-Garcia; Amy R Noe; Christian Muñoz; Russell Coleman; Torben Bruck; Keith Haney; Alex Stevens; Diane Retallack; Jeff Allen; Thomas S Vedvick; Christopher B Fox; Steven G Reed; Randall F Howard; Ahmed M Salman; Chris J Janse; Shahid M Khan; Fidel Zavala; Gabriel M Gutierrez
Journal:  Infect Immun       Date:  2017-01-26       Impact factor: 3.441

7.  Efficient recovery of recombinant CRM197 expressed as inclusion bodies in E.coli.

Authors:  Ah-Reum Park; Seung-Won Jang; Jin-Sook Kim; Young-Gyun Park; Bong-Seong Koo; Hyeon-Cheol Lee
Journal:  PLoS One       Date:  2018-07-18       Impact factor: 3.240

8.  Non-Invasive Analysis of Recombinant mRNA Stability in Escherichia coli by a Combination of Transcriptional Inducer Wash-Out and qRT-PCR.

Authors:  Veronika Kucharova; Trine Aakvik Strand; Eivind Almaas; Adrian E Naas; Trygve Brautaset; Svein Valla
Journal:  PLoS One       Date:  2013-06-19       Impact factor: 3.240

9.  Bacterial cell factories for recombinant protein production; expanding the catalogue.

Authors:  Neus Ferrer-Miralles; Antonio Villaverde
Journal:  Microb Cell Fact       Date:  2013-11-18       Impact factor: 5.328

10.  A full-length Plasmodium falciparum recombinant circumsporozoite protein expressed by Pseudomonas fluorescens platform as a malaria vaccine candidate.

Authors:  Amy R Noe; Diego Espinosa; Xiangming Li; Jordana G A Coelho-Dos-Reis; Ryota Funakoshi; Steve Giardina; Hongfan Jin; Diane M Retallack; Ryan Haverstock; Jeffrey R Allen; Thomas S Vedvick; Christopher B Fox; Steven G Reed; Ramses Ayala; Brian Roberts; Scott B Winram; John Sacci; Moriya Tsuji; Fidel Zavala; Gabriel M Gutierrez
Journal:  PLoS One       Date:  2014-09-23       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.